Evidence map›Paper›PMID 31673427›Full record

ArticleESMO open2019

Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: a case report and a review of literature.

Giuseppe Viscardi, Nicoletta Zanaletti, Maria Giovanna Ferrara, Antonello Sica, Umberto Falcone, Salvatore Guastafierro, Umberto Bracale, Dario Ribero, Morena Fasano, Stefania Napolitano and 7 more

Open access · goldAbstract read
In one paragraph

Article in ESMO open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Giuseppe Viscardi *Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.ORCID 0000-0003-4473-9387
Nicoletta Zanaletti *Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Maria Giovanna FerraraOncohematology Unit, AOU Luigi Vanvitelli, Naples, Italy.
Antonello SicaOncohematology Unit, AOU Luigi Vanvitelli, Naples, Italy.
Umberto FalconeOncohematology Unit, AOU Luigi Vanvitelli, Naples, Italy.
Salvatore GuastafierroOncohematology Unit, AOU Luigi Vanvitelli, Naples, Italy.
Umberto BracaleDepartment of Endocrinology, Gastroenterology and Endoscopic Surgery, Università degli Studi di Napoli Federico II, Naples, Italy.
Dario RiberoHepatobilio-Pancreatic and Colorectal Surgery Unit, Candiolo Cancer Institute-FPO IRCCS, Candiolo, Italy.
Morena FasanoMedical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Stefania NapolitanoMedical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Pasquale VitaleMedical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Vincenzo De FalcoMedical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Emilio Francesco GiuntaMedical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Erika MartinelliMedical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Davide CiardielloMedical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Fortunato CiardielloMedical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Teresa TroianiMedical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
University of Campania "Luigi Vanvitelli" · ITCandiolo Cancer Institute · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atypical haemolytic-uraemic syndromecolorectal cancereculizumabthrombotic microangiopathies

Identifiers

PMID31673427
PMCPMC6802959
OpenAlexW2973470021

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.